GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » 3-Year FCF Growth Rate

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) 3-Year FCF Growth Rate : -32.60% (As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings 3-Year FCF Growth Rate?

Oxford Cannabinoid Technologies Holdings's Free Cash Flow per Share for the six months ended in Oct. 2023 was £-0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -32.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 5 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Oxford Cannabinoid Technologies Holdings was -32.60% per year. The lowest was -32.60% per year. And the median was -32.60% per year.


Competitive Comparison of Oxford Cannabinoid Technologies Holdings's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's 3-Year FCF Growth Rate falls into.



Oxford Cannabinoid Technologies Holdings 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Oxford Cannabinoid Technologies Holdings  (LSE:OCTP) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Oxford Cannabinoid Technologies Holdings 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Headlines

No Headlines